Nov 4 (Reuters) - Pharming Group Nv
* Pharming confirms receipt of $20 million milestone paymentfrom Salix Pharmaceuticals
* Milestone paid according to terms and conditions ofRuconest commercialization agreement between Salix and Pharming
* Receipt of milestone payment strengthens company'sdebt-free balance sheet to more than 38 million eurosSource text for Eikon: Further company coverage: (Gdynia Newsroom: +48 58 698 39 20;Gdynia.newsroom@thomsonreuters.com)
* Pharming confirms receipt of $20 million milestone paymentfrom Salix Pharmaceuticals
* Milestone paid according to terms and conditions ofRuconest commercialization agreement between Salix and Pharming
* Receipt of milestone payment strengthens company'sdebt-free balance sheet to more than 38 million eurosSource text for Eikon: Further company coverage: (Gdynia Newsroom: +48 58 698 39 20;Gdynia.newsroom@thomsonreuters.com)
via Smart Health Shop Forum http://ift.tt/1x6WhzL
No comments:
Post a Comment